Atlas Arteria Limited (ASX:ALX)
Australia · Delayed Price · Currency is AUD | Market Cap | 5.81B -24.2% |
| Revenue (ttm) | 156.80M +2.0% |
| Net Income | 268.70M -10.1% |
| EPS | 0.18 -10.3% |
| Shares Out | 1.45B |
| PE Ratio | 21.65 |
| Forward PE | 16.04 |
| Dividend | 0.40 (10.00%) |
| Ex-Dividend Date | Sep 23, 2026 |
| Volume | 4,263,163 |
| Open | 4.120 |
| Previous Close | 4.160 |
| Day's Range | 4.000 - 4.140 |
| 52-Week Range | 4.000 - 5.235 |
| Beta | 0.52 |
| Analysts | Hold |
| Price Target | 4.76 (+19.0%) |
| Earnings Date | Aug 27, 2026 |
About Atlas Arteria
Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. Atlas Arteria Limited was formerly known as... [Read more]
Financial Performance
In 2025, Atlas Arteria's revenue was 160.00 million, an increase of 9.66% compared to the previous year's 145.90 million. Earnings were 259.50 million, a decrease of -22.74%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for ALX stock is "Hold." The 12-month stock price target is $4.76, which is an increase of 19.00% from the latest price.
News
Atlas Arteria upgraded to Buy from Hold at Jefferies
Jefferies upgraded Atlas Arteria (MAQAF) to Buy from Hold with a A$5.31 price target following first half results that the firm calls “broadly in-line with expectations.” The company’s strategy has…
Atlas Arteria Earnings Call Transcript: H1 2026
Underlying performance was stable with modest growth in constant currency terms, but FX headwinds and non-operating costs led to a statutory loss. Distribution guidance for 2026 is reaffirmed, with future payouts tied to free cash flow. IFM's increased stake and board changes mark a strategic transition.
Atlas Arteria Quarterly report: H1 2026
Atlas Arteria has published its H1 2026 quarterly earnings report on August 26, 2026.
Atlas Arteria Earnings release: H1 2026
Atlas Arteria released its H1 2026 earnings on August 26, 2026, summarizing the period's financial results.
Atlas Arteria Slides: H1 2026
Atlas Arteria has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 26, 2026.
Atlas Arteria Earnings release: Q2 2026
Atlas Arteria released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
Atlas Arteria downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital downgraded Atlas Arteria (MAQAF) to Underperform from Sector Perform with a A$4.75 price target The firm is concerned that the company will become “very illiquid” post the IFM…
IFM Global proposes 'best and final' bid for Australia's Atlas Arteria of $5.2 billion
IFM Global Infrastructure Fund sweetened its takeover bid for Australia's Atlas Arteria on Monday to A$7.40 billion ($5.24 billion), calling the revised offer its "best and final" proposal and sayin...
Atlas Arteria's independent expert finds IFM Global's offer not fair or reasonable
Australia's Atlas Arteria said on Tuesday that its independent expert reinforced the company's earlier rejection of IFM Global Infrastructure Fund's proposal to buy the toll road operator at a valua...
Atlas Arteria Transcript: AGM 2026
The AGM highlighted strong 2025 financial results, reaffirmed 2026 distribution guidance, and detailed ongoing strategic initiatives, including a potential Chicago Skyway sale. The board unanimously recommended rejecting IFM's hostile takeover bid, citing undervaluation and risks. All resolutions received sufficient support to pass.
Australia's Atlas Arteria logs best day since June 2022 on $4.9 billion buyout offer
Atlas Arteria shares rose more than 13% on Monday after IFM Global Infrastructure Fund offered to acquire all the shares it does not currently own in the Australian toll operator, valuing it at A$6.8...
Atlas Arteria Earnings release: Q1 2026
Atlas Arteria released its Q1 2026 earnings on April 21, 2026, summarizing the period's financial results.
Atlas Arteria Earnings Call Transcript: H2 2025
Proportional toll revenue and EBITDA grew over 9% year-over-year, supported by traffic growth and CPI-linked toll increases, while free cash flow per security dipped due to the French TST. Distribution remains stable at AUD 0.40 per security, with the same guidance for 2026.
Atlas Arteria Annual report: H2 2025
Atlas Arteria has published its H2 2025 annual report on February 25, 2026.
Atlas Arteria Slides: H2 2025
Atlas Arteria has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 25, 2026.
Atlas Arteria Earnings release: H2 2025
Atlas Arteria released its H2 2025 earnings on February 25, 2026, summarizing the period's financial results.
Atlas Arteria Earnings Call Transcript: H1 2025
Proportional toll revenue and EBITDA rose 8% year-over-year, while net profit fell 33% due to a one-time French tax. Distribution guidance of $0.40 per security for 2025 is maintained, with strong free cash flow and no plans for new equity issuance.
Atlas Arteria Quarterly report: H1 2025
Atlas Arteria has published its H1 2025 quarterly earnings report on August 27, 2025.
Atlas Arteria Slides: H1 2025
Atlas Arteria has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 27, 2025.
Atlas Arteria Earnings release: H1 2025
Atlas Arteria released its H1 2025 earnings on August 27, 2025, summarizing the period's financial results.
Atlas Arteria Transcript: AGM 2025
The AGM highlighted strong toll revenue growth, a new distribution policy, and ongoing legal and regulatory challenges in France and the U.S. Board renewal, enhanced governance, and sustainability initiatives were emphasized, with all resolutions supported by major shareholders.
Atlas Arteria Slides: Company Presentation
Atlas Arteria has posted slides in relation to its latest quarterly earnings report, which was published on May 7, 2025.
Atlas Arteria Earnings release: Q1 2025
Atlas Arteria released its Q1 2025 earnings on April 23, 2025, summarizing the period's financial results.
Atlas Arteria Earnings Call Transcript: H2 2024
Proportional revenue and EBITDA grew in 2024, supported by toll increases and steady traffic, despite headwinds from new French taxes and regulatory challenges in the US. Distribution guidance remains at AUD 0.40 per security for 2025, with a new policy to pay 90%-110% of free cash flow.
Atlas Arteria Annual report: H2 2024
Atlas Arteria has published its H2 2024 annual report on February 26, 2025.